Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
Launched by INNOVATIVE MEDICAL · Dec 3, 2007
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Using computers more than three hours per day
- • Having dry eye symptoms based on results on the OSDI Scores of 15 or greater on the OSDI will be considered to have the disorder
- • An abnormal confocal image of 5 or greater.
- Exclusion Criteria:
- • All corneal disorders except for tear disorders.
About Innovative Medical
Innovative Medical is a forward-thinking clinical trial sponsor dedicated to advancing healthcare through the development of groundbreaking therapies and medical technologies. With a focus on patient-centric research, Innovative Medical collaborates with leading healthcare professionals and institutions to conduct rigorous clinical trials that adhere to the highest standards of safety and efficacy. The organization is committed to fostering innovation and improving patient outcomes by bridging the gap between scientific discovery and real-world application, ultimately contributing to the evolution of modern medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
6400 Fannin Ste 1800, Texas, United States
Patients applied
Trial Officials
Richard Yee, MD
Principal Investigator
Hermann Eye Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials